Key result
Chemotherapy-induced cardiotoxicity is a significant side effect of various cancer treatments, necessitating careful monitoring, early detection, and a multidisciplinary approach.
Why the study?
What are the cardiotoxic effects, mechanisms, and treatments associated with different groups of cytotoxic agents in cancer patients?
What are the cardiotoxic effects, mechanisms, and treatments associated with different groups of cytotoxic agents in cancer patients?
This review provides a comprehensive overview of chemotherapy-induced cardiotoxicity, emphasizing the critical need for early stratification and continuous multidisciplinary monitoring by cardiologists and oncologists.
Answers are grounded in this paper and cite their sources.
Genetic variation may modify chemotherapy cardiotoxicity risk; leaves open personalized dosing strategies pending validation.
Cardiotoxicity is one of the most important side effects of first-line chemotherapy medications. It is influenced by genetic variation, whereby the relationship between the chemotherapeutic dose and the risk of cardiotoxicity can be altered. The incidence of cardiotoxicity depends on the substance used in the therapeutic modality of cancer and can reach an incidence of 30% during a three-year follow-up. The main element of the clinical picture is systolic dysfunction of the left ventricle, with symptoms of heart failure, which can change or stop oncological therapy, along with pharmacological treatment of heart failure. These symptoms can occur during prolonged use of cancer therapies, monitoring the patient is advisable. Considering the increasing success of oncology therapy and the extension of life, as well as the improvement of the quality of life, a multidisciplinary approach, as well as the symbiosis of the work of cardiologists and oncologists, is imperative. Patient stratification concerning oncological treatment modality is imposed as part of a cardiologist's daily work from the beginning of cancer treatment.
No takes yet. Share an insight, caveat, or question.
Begić et al. (2023) conducted a review in Chemotherapy-induced cardiotoxicity. Cytotoxic chemotherapy agents was evaluated. Chemotherapy-induced cardiotoxicity is a significant side effect of various cancer treatments, necessitating careful monitoring, early detection, and a multidisciplinary approach.
Synapse has enriched 10 related papers. Consider them for comparative context: